›› 2011, Vol. 23 ›› Issue (1): 50-053.doi: 10.3969/j.issn.1004-616x.2011.01.013

• 肿瘤防治 • Previous Articles     Next Articles

Effects of Ashitaba chalcone on Caspase-3 and Bax protein expressions of mouse hepatocarcinoma cells

MENG Yang,ZHONG Jin-yi*,SUN He   

  1. Medical College of Qingdao University, Qingdao Shandong, China
  • Received:2010-09-10 Revised:2010-11-18 Online:2011-01-30 Published:2011-01-30
  • Contact: ZHONG Jin-yi

Abstract: To investigate the effects of Ashitaba chalcone (AC) on Caspase-3 and Bax protein expressions in mouse hepatocarcinoma cells. METHODS: Fifty mice inoculated with hepatocarcinoma 22 cells were divided into five groups, 10 mice per group. 5,20,40 mg/kg AC were given daily by mouth to form low, medium and high dose groups, respectively. Normal saline by mouth was given to the tumor control group. 20 mg/kg cytoxan(CTX) by injection every other day were given to the CTX group.10 days later, all mice were sacrificed. The levels of the Caspase-3 and Bax protein expressions were measured by immunohistochemistry, and the proliferation activity of hepatocarcinoma cells was determined by MTT assay. RESULTS: The expressions level of Caspase-3 and Bax protein in tumor control group were 5.00% and 4.68%, respectively, and those of the high-dose group were 38.52% and 35.76%. The differences between two groups were significant (P<0.05). The cell proliferation activity of tumor control group and high-dose group were 1.135±0.032 and 0.716±0.018, respectively. The difference was significant (P<0.05). The rumor weight in AC 20, 40 mg/kg were significantly lower than that in tumor control group (P<0.05). CONCLUSION: AC could induce the expressions of Caspase-3 and Bax protein.

Key words: Ashitaba chalcone, hepatocarcinoma, Caspase-3, Bax